Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $27.08 in the last session, down -2.24% from day before closing price of $27.70. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 1.03 million shares were traded. AKRO stock price reached its highest trading level at $27.77 during the session, while it also had its lowest trading level at $26.66.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 30.12 and its Current Ratio is at 30.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’24 when Young Jonathan sold 5,000 shares for $23.40 per share. The transaction valued at 117,020 led to the insider holds 246,854 shares of the business.
Cheng Andrew sold 7,894 shares of AKRO for $178,728 on Jun 11 ’24. The President and CEO now owns 581,553 shares after completing the transaction at $22.64 per share. On Jun 11 ’24, another insider, White William Richard, who serves as the Chief Financial Officer of the company, sold 2,831 shares for $22.64 each. As a result, the insider received 64,094 and left with 46,799 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1915482112 and an Enterprise Value of 1004764288.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $53.77, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 23.65%, while the 200-Day Moving Average is calculated to be 22.61%.
Shares Statistics:
According to the various share statistics, AKRO traded on average about 801.35K shares per day over the past 3-months and 808302 shares per day over the past 10 days. A total of 69.15M shares are outstanding, with a floating share count of 57.87M. Insiders hold about 16.31% of the company’s shares, while institutions hold 99.14% stake in the company. Shares short for AKRO as of 1719532800 were 6467326 with a Short Ratio of 8.07, compared to 1717113600 on 7457353. Therefore, it implies a Short% of Shares Outstanding of 6467326 and a Short% of Float of 9.629999999999999.
